Innovative treatment for Hepatitis C virus

Introduction

Hepatitis C virus (HCV) infection is a major public health challenge for Australia. Acute infection progresses to chronic disease in up to 75% of cases, and these people are at risk of progressive liver fibrosis leading to cirrhosis, liver failure and hepatocellular carcinoma (HCC). Around 20%–30% of people with chronic HCV infection will develop cirrhosis, generally after 20–30 years of infection. Continue reading

Intestinal parasites update

The role of intestinal parasites such as Giardia Lamblia and Cryptosporidium in causing human disease is well known. More recently due to improvements in diagnostic tests, other parasites are also being recognized as pathogens. This is expanding the list of “single word answers” to chronic gastrointestinal complaints such as diarrhea predominant irritable bowel syndrome. Continue reading